I guarantee weight loss would be on Dr T's list of potential uses of Bisantrene.
This is a grab from a global drug forecast and market analysis. As we can see, total expected sales in 2022 are (I'm assuming USD) USD $8.4 B. Another grab from a report states that "The Global Anti-obesity Prescription Drugs Market is expected to grow from USD 9,909.80 Million in 2019 to USD 16,094.08 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.41%".
It seems that any further information is limited, as many market analysts have looked into this, but there are few who are prepared to share their research for free.
Pillar 1 - FTO (new thread), page-32
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.035(2.18%) |
Mkt cap ! $266.3M | |||
| Open | High | Low | Value | Volume |
| $1.59 | $1.62 | $1.56 | $101.6K | 64.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7451 | $1.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.60 | 408 | 1 |
View Market Depth
| Last trade - 15.53pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.58 |
Change
-0.035 ( 1.25 %) |
||||
| Open | High | Low | Volume | ||
| $1.58 | $1.62 | $1.56 | 7255 | ||
| Last updated 15.57pm 05/06/2024 ? | |||||
| RAC (ASX) Chart |